Now that the dust of February has settled, investors can start looking for some stocks that had an abysmal month. While the Nasdaq-100 fell 2.6% in February, a few stocks had an even worse performance.

The stocks claiming this "honor" were JD.com (NASDAQ: JD), SiriusXM (NASDAQ: SIRI), and Moderna (NASDAQ: MRNA). But are any of them worth buying now? Let's find out.

The worst-performing Nasdaq-100 stock in February was JD.com, down 27%. JD.com is China's largest online and overall retailer, so its dynamics significantly differ from those of a company based in the U.S.

Continue reading

Source Fool.com